FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Bansal Wire IPO and Emcure Pharma IPO.
Bansal Wire IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Bansal Wire IPO | Emcure Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | SBI Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) |
Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | |
Anchor Investor | ||
IPO Allotment URL |
The total issue size of Bansal Wire IPO is up to ₹745.00 Cr whereas the issue size of the Emcure Pharma IPO is . The final issue price of Bansal Wire IPO is and of Emcure Pharma IPO is .
Bansal Wire IPO | Emcure Pharma IPO | |
---|---|---|
Face Value | ₹5 per share | ₹10 per share |
Issue Price (Lower) | ₹243.00 per share | |
Issue Price (Upper) | ₹256.00 per share | |
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 58 shares | |
Fresh Issue Size | 2,91,01,562 shares | |
Fresh Issue Size (Amount) | up to ₹745.00 Cr | up to ₹800.00 Cr |
OFS Issue Size | 1,36,78,839 shares | |
OFS Issue Size (Amount) | ||
Issue Size Total | 2,91,01,562 shares | |
Issue Size Total (Amount) | up to ₹745.00 Cr |
Bansal Wire IPO opens on Jul 03, 2024, while Emcure Pharma IPO opens on . The closing date of Bansal Wire IPO and Emcure Pharma IPO is Jul 05, 2024, and , respectively.
Bansal Wire IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Bid Date | Jul 02, 2024 | |
Issue Open | Jul 03, 2024 | |
Issue Close | Jul 05, 2024 | |
Basis Of Allotment (Tentative) | Jul 08, 2024 | |
Initiation of Refunds (Tentative) | Jul 09, 2024 | |
Credit of Share (Tentative) | Jul 09, 2024 | |
Listing date (Tentative) | Jul 10, 2024 | |
Anchor Lockin End date 1 | Aug 07, 2024 | |
Anchor Lockin End date 2 | Oct 06, 2024 |
Bansal Wire IPO P/E ratio is 41.41, as compared to Emcure Pharma IPO P/E ratio of .
Bansal Wire IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Bansal Wire Industries Limited Financial Information (Restated)Bansal Wire Industries Limited's revenue increased by 1.99% and profit after tax (PAT) rose by 31.48% between the financial year ending with March 31, 2024 and March 31, 2023.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 95.78% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 41.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹4007.83 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 21.19%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 18.46%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹6.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 18.27%% |
In the Bansal Wire IPO retail investors (RII) are offered while in Emcure Pharma IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bansal Wire IPO and in Emcure Pharma IPO.
Bansal Wire IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Bansal Wire IPO subscribed in total, whereas Emcure Pharma IPO subscribed .
Bansal Wire IPO | Emcure Pharma IPO | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|